[Bitemporal hemianopia in road traffic].
BACKGROUND
Patients suffering from pituitary adenomas and diseases of the chiasma typically show a bitemporal hemianopia. The residual undisturbed nasal visual fields of both eyes should have an extension of (at least) 120 degrees and are according to the actual German traffic rules (FeVAndV) for cars of the classes A, B, M, L and T. The intact half fields fit geometrically to one virtual normal field, that seems to correspond in the centre of a normal field. Reports on this problem often do not address correctly the questions of suitability for participation in road traffic.


METHODS
The case of a patient with typical bitemporal hemianopia illustrates the sensorial peculiarities: the functioning temporal retinal halves do not correspond. This patient suffered additionally from disturbing diplopia due to a small-angle exotropia. The extent of the performed eye muscle surgery was selected to induce a slight overcorrection, i. e., resulting in 3 to 5 degrees esotropia. This eliminated the diplopia, but resulted in a vertical scotoma of the extension of the esotropia.


CONCLUSIONS
In bitemporal hemianopia the undisturbed nasal visual half fields do not add up to a "nearly normal field of one eye". Moreover, either diplopia or--much more dangerous in traffic--a central vertical scotoma is the result. The explanation for this is a sliding of the hemifields of each eye without stabilisation by corresponding areas of the retinas of the right and left eyes. The peripheral extension of the visual field is not the key to the problem to imagine how a patient with typical bitemporal hemianopia will visualise daily life and traffic. In bitemporal hemianopia there is substantially no eligibility for driving a car or motor bicycle in road traffic.
Krzizok
T
T
Augenklinik am Klinikum Bad Hersfeld. thomas.krzizok@web.de
Schwerdtfeger
G
G
D000328:Adult; D001333:Automobile Driver Examination; D001334:Automobile Driving; D006423:Hemianopsia / Q000175:diagnosis* / Q000601:surgery*; D006801:Humans; D008297:Male; D016896:Treatment Outcome